Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Assets Average (2016 - 2025)

Dexcom (DXCM) has disclosed Assets Average for 14 consecutive years, with $7.0 billion as the latest value for Q2 2025.

  • On a quarterly basis, Assets Average changed N/A to $7.0 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $7.0 billion, a N/A change, with the full-year FY2025 number at $6.4 billion, up 0.59% from a year prior.
  • Assets Average was $7.0 billion for Q2 2025 at Dexcom, up from $6.6 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $7.0 billion in Q2 2025 to a low of $4.3 billion in Q1 2021.
  • A 4-year average of $5.7 billion and a median of $5.7 billion in 2022 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: soared 79.24% in 2021, then grew 15.09% in 2022.
  • Dexcom's Assets Average stood at $4.9 billion in 2021, then rose by 2.9% to $5.0 billion in 2022, then rose by 28.73% to $6.4 billion in 2023, then increased by 9.47% to $7.0 billion in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Assets Average are $7.0 billion (Q2 2025), $6.6 billion (Q1 2025), and $6.4 billion (Q4 2023).